What is the appropriate dosing regimen of oral nystatin for treating oral candidiasis in adults and in children younger than two years?

Nystatin Dosing for Oral Candidiasis

For mild oral candidiasis in adults, use nystatin suspension 100,000 U/mL at 4-6 mL (400,000-600,000 units) four times daily for 7-14 days, though clotrimazole troches or miconazole buccal tablets are preferred first-line options due to superior efficacy. 1

Adult Dosing

Standard Regimen

• Nystatin suspension (100,000 U/mL): 4-6 mL four times daily for 7-14 days 2
• Instruct patients to swish half the dose in each side of the mouth and retain as long as possible before swallowing 2
• Continue treatment for at least 48 hours after symptoms resolve and cultures confirm Candida eradication 2

Clinical Context

• Nystatin is recommended as an alternative agent for mild disease only, not first-line therapy 1
• Clotrimazole troches (10 mg 5 times daily) or miconazole mucoadhesive buccal tablets (50 mg once daily) are preferred for mild oral candidiasis with strong recommendation and high-quality evidence 1
• For moderate to severe disease, oral fluconazole 100-200 mg daily for 7-14 days is the recommended treatment, not nystatin 1

Pediatric Dosing

Infants and Young Children

• 2 mL (200,000 units) four times daily 2
• Use dropper to place half the dose (1 mL) in each side of mouth 2
• Avoid feeding for 5-10 minutes after administration 2

Premature and Low Birth Weight Infants

• 1 mL (100,000 units) four times daily has been shown effective in limited clinical studies 2

Important Caveats and Limitations

Efficacy Concerns

• Nystatin has significantly lower cure rates compared to fluconazole and other azoles in multiple randomized trials 3, 4, 5
• In HIV-infected patients, nystatin achieved only 52% clinical cure versus 87% with fluconazole at day 14 4
• In infants, nystatin showed only 32% cure rate compared to 100% with fluconazole 3
• Nystatin is associated with higher relapse rates (44% vs 18% with fluconazole) 4

When Nystatin May Be Appropriate

• Patients who cannot tolerate or afford systemic azole therapy 1
• Very mild disease where topical therapy is sufficient 1
• Situations where systemic absorption must be avoided 2

Compliance Issues

• Patients report significantly more inconvenience with nystatin (mean value 25.9) compared to fluconazole (mean value 6.6), which may impact adherence 5
• Four-times-daily dosing is more burdensome than once-daily alternatives 2, 5

Special Populations

Denture-Related Candidiasis

• Antifungal therapy alone is insufficient 1
• Denture disinfection is mandatory in addition to nystatin treatment 1
• Consider denture soaking solutions containing nystatin (10,000 IU/mL) as adjunctive therapy 6

Immunocompromised Patients

• Nystatin is not recommended for immunocompromised patients including those with HIV 1, 4
• These patients require systemic therapy with fluconazole or other azoles 1
• HIV-infected patients should receive antiretroviral therapy to reduce recurrence 1

Duration and Follow-Up

• Minimum treatment duration: 7-14 days 1
• Continue for at least 48 hours after symptom resolution and negative cultures 2
• Chronic suppressive therapy with nystatin is not recommended; if needed, use fluconazole 100 mg three times weekly instead 1